Glenn Prives, Member of the Firm, co-presents a webinar, “Due Diligence in Healthcare Private Equity Transactions,” hosted by Strafford.
Private equity firms play an active role in health care deals. As with any health care deal, the parties involved in health care private equity transactions should conduct thorough due diligence before closing the deal. The parties should consider potential successor liability, pending or threatened litigation, current contracts that could trigger penalties, and more. Because health care entities are highly regulated, parties to these transactions should conduct significant health care regulatory due diligence.
Counsel should also review current ownership structures to minimize the risk of corporate practice of medicine issues. Other regulatory considerations during the due diligence process include compliance with Stark Law, Anti-Kickback Statute, False Claims Act, and HIPAA, as well as the state law equivalents.
Glenn and others examine due diligence in health care private equity transactions and why the due diligence process should be carefully structured and implemented. The panel discusses the legal issues to address in health care due diligence, including key health care risk areas and requirements, compliance programs, Medicare/Medicaid changes of ownership, licenses, and permits. The panel offers best practices for conducting due diligence in health care transactions.
For more information and to register, please visit StraffordPub.com.